Explore the clinical and dermoscopic features of mixed-type basal cell carcinoma and how subtype patterns may support diagnosis and treatment decisions.
Read More
Read our articles for the latest updates and to learn more about
MoleMax Systems and Skin Imaging Device.
QSkin data reveals the rising cost of skin cancer in Australia, with keratinocyte cancer and melanoma expenditure increasing sharply over a decade.
See how an AI skin cancer detection system analyses lesions, supports clinical decisions and helps clinics improve triage, consistency and screening capacity.
Discover how mole mapping technology combines total body photography, dermoscopy and change tracking to support earlier melanoma detection and monitoring.
Compare AI melanoma detection systems for clinics, including how they work, accuracy, limitations, workflow integration and key options available in 2026.
Review which dermoscopic features best distinguish acral lentiginous melanoma from benign acral nevi and support earlier, standardised diagnosis.
How does artificial intelligence (AI) diagnostic performance compare to human dermatologists of varying experience for skin cancer detection in realistic clinical settings?
Malignant skin cancers impose an escalating and heterogeneous health burden worldwide.
Skin cancer risk factors in asymptomatic screening patients
A critical review of melanocytic tumor classification
Key factors influencing recurrence in early-stage melanoma
Spontaneous regression observed after biopsy of squamous carcinoma
